Understanding Immune Checkpoint Inhibitor Treatment Outcomes in Cancer Survivors
Official title: Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
Funded at Roswell Park Cancer Institute Corp · NIH-11074667 · Data updated 2026-11-12
This project looks at how immune checkpoint inhibitor treatments work for cancer survivors, especially those of African ancestry, in everyday cancer clinics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | June 1, 2021 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $2,425,687 |
| NIH project number | 5UH3CA260602-05 |
| Project ID | NIH-11074667 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are cancer survivors who have received immune checkpoint inhibitor treatment, particularly those of African or European ancestry.
✕Less likely to help
Patients who have not received immune checkpoint inhibitor treatment or do not have advanced cancer may not directly benefit from this specific research.
What this research studies
Immune checkpoint inhibitors are powerful cancer treatments, but we don't know much about how they affect patients of African ancestry. This project will follow cancer survivors who have received these treatments in community cancer centers. We want to understand if there are differences in how well the treatments work, what side effects occur, and how they impact long-term quality of life for patients of African ancestry compared to those of European ancestry. This will help us learn more about how these important medicines work for everyone.
Why it matters
Potential benefit: If successful, this work could lead to more personalized and effective cancer care for patients of African ancestry, potentially reducing health disparities.
How similar studies have gone: While immune checkpoint inhibitors have shown broad success, there is limited data specifically on their outcomes and toxicities in patients of African ancestry in community settings, making this a novel focus.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Ambrosone, Christine B. — Roswell Park Cancer Institute Corp
- Study coordinator: Ambrosone, Christine B.
Related research
Other NIH-funded projects on the same topics.
-
Disparities in Immunotherapy Outcomes for African Ancestry Cancer Patients in Community Settings
This project follows cancer patients treated with anti-PD-1/PD-L1 therapies in community clinics to understand how racial background may influence treatment results and side effects.
-
Telehealth exercise program to help rural breast cancer survivors fight fatigue
A telehealth exercise program is being tested to reduce cancer-related fatigue in rural breast cancer survivors.
-
Understanding how survivorship care plans affect health outcomes for cancer survivors
A study will look at whether survivorship care plans help reduce deaths and improve health for adults who have survived cancer.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Social connections and quality of life for kids who survived brain cancer
This project follows pediatric brain cancer survivors as they grow into adults to understand how their social connections affect their happiness and mental well-being.
-
Nutrition and exercise plan to help overweight cancer survivors, using multi-omics to tailor care
A cancer survivorship program combines a tailored diet and exercise plan with multi-omics data to personalize care for adults with overweight or obesity.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.